Your browser is no longer supported. Please, upgrade your browser.
Settings
VHT Vanguard Health Care ETF daily Stock Chart
VHT [NYSE]
Vanguard Health Care ETF
Index- P/E- EPS (ttm)- Insider Own- Shs Outstand- Perf Week1.63%
Market Cap- Forward P/E- EPS next Y- Insider Trans- Shs Float- Perf Month-1.01%
Income- PEG- EPS next Q- Inst Own- Short Float- Perf Quarter5.93%
Sales- P/S- EPS this Y- Inst Trans- Short Ratio1.09 Perf Half Y12.94%
Book/sh- P/B- EPS next Y- ROA- Target Price- Perf Year13.86%
Cash/sh- P/C- EPS next 5Y- ROE- 52W Range148.31 - 181.92 Perf YTD14.21%
Dividend2.06 P/FCF- EPS past 5Y- ROI- 52W High-3.23% Beta-
Dividend %1.17% Quick Ratio- Sales past 5Y- Gross Margin- 52W Low18.70% ATR2.32
Employees- Current Ratio- Sales Q/Q- Oper. Margin- RSI (14)50.55 Volatility1.92% 1.17%
OptionableYes Debt/Eq- EPS Q/Q- Profit Margin- Rel Volume1.76 Prev Close175.32
ShortableYes LT Debt/Eq- Earnings- Payout- Avg Volume224.54K Price176.04
Recom- SMA20-0.65% SMA500.26% SMA2007.50% Volume396,123 Change0.41%
Oct-10-18 11:51AM  Health Care ETFs Retreat on DOJ Approval of Aetna-CVS Merger ETF Trends
Oct-04-18 09:15AM  Dow Closes at Another New High Zacks
Oct-03-18 06:00AM  Why Stock Market's 'Out of Whack' Leadership Signals Next Crash Investopedia
Sep-25-18 03:05PM  New Innovation Spurring a Biotech Rejuvenation Harvest Exchange
Sep-17-18 08:00AM  Online Retail, Small-Cap Stocks Among Market Pro's Top Picks Investor's Business Daily
Sep-10-18 06:00AM  Top 3 Healthcare ETFs for 2018 Investopedia
Aug-28-18 06:40PM  3 ETFs for Johnson & Johnson's Healthy Breakout Investopedia
Aug-22-18 03:22PM  7 Healthcare ETFs Among Best Performing Defensive Picks This Year ETF Trends
10:41AM  Investors Flock to This Vanguard Sector ETF ETF Trends
Aug-09-18 12:45PM  Investors Flocked to Healthcare ETFs in July ETF Trends
Aug-06-18 12:10PM  5 ETFs for a Historically Low August InvestorPlace
Aug-03-18 06:57PM  5 ETFs for a Historically Low August Zacks
Jun-20-18 08:05AM  E*TRADE Adds Several of Todays Most Popular ETFs to Commission-Free ETF Lineup Business Wire
May-21-18 12:41PM  3 Top Index Funds to Keep You in the Investing Game Motley Fool
Apr-05-18 11:55AM  The 3 Best Low-Cost Retirement Funds InvestorPlace
Mar-24-18 10:47AM  How to Invest in Healthcare Stocks the Easy Way Motley Fool
Jan-26-18 07:33AM  What Are Pfizers Positive Growth Contributors? Market Realist
Jan-25-18 07:32AM  What Led to Arrowhead Pharmaceuticals Revenue Surge in 2017? Market Realist
Jan-22-18 07:32AM  Merck & Co.s Cardiovascular and Immunology Products in 3Q17 Market Realist
Jan-19-18 11:05AM  Johnson & Johnsons Pharmaceutical Segment: 4Q17 Estimates Market Realist
Jan-15-18 07:37AM  Insys Has Legal Issues Galore Market Realist
Jan-12-18 12:20PM  Whats the Competitive Landscape for Accelerate Diagnostics? Market Realist
Jan-11-18 02:55PM  3 Vanguard ETFs for Retired Investors to Buy Right Now InvestorPlace
10:49AM  3 Trades That Will Make You $1,000 This Month InvestorPlace
Jan-09-18 10:48AM  7 Best Healthcare ETFs for 2018 InvestorPlace
10:23AM  Examining Incytes Quarterly Revenue Trend Market Realist
Jan-04-18 01:07PM  A Healthy Vanguard Sector ETF ETF Trends
Jan-03-18 11:06AM  The Vanguard Health Care ETF Is a Strong Buy After Its Powerful Rally InvestorPlace
Nov-21-17 09:02AM  Merck: Diabetes, General Medicine, and Womens Health after 3Q17 Market Realist
Nov-14-17 06:59PM  Top 3 Healthcare ETFs for 2017 Investopedia
Oct-24-17 07:40AM  What Analysts Recommend for Eli Lilly Market Realist
Oct-03-17 07:42AM  Quarterly Performance of Eli Lillys New Products Market Realist
Sep-18-17 09:07AM  Regeneron Is Focused on Advancing Development of Fasinumab for Chronic Pain Market Realist
Sep-15-17 03:39PM  What Analysts Recommend for Sage Therapeutics Market Realist
Sep-08-17 09:07AM  Behind Mercks Revenues in 2Q17 Market Realist
Sep-07-17 04:35PM  Behind Jazzs Strategic Collaboration with ImmunoGen Market Realist
Sep-01-17 09:08AM  Eli Lillys New Products in 2Q17 Market Realist
Aug-30-17 07:37AM  Performance of Bristol-Myers Squibbs Opdivo in 2Q17 Market Realist
Aug-29-17 10:38AM  How Innovation Is Driving Becton Dickinsons Growth in 2017 Market Realist
09:08AM  Johnson & Johnsons Pharmaceuticals Segment in 2Q17 Market Realist
Aug-23-17 09:07AM  Key Developments for Allergan in 2Q17 Market Realist
07:37AM  Behind Incytes 2Q17 Product Portfolio Market Realist
07:37AM  Inside the Efficacy of JAZZs JZP-110 for Excessive Sleepiness Market Realist
Aug-18-17 07:39AM  Analysts Recommendations for Bristol-Myers Squibb in August 2017 Market Realist
Aug-16-17 10:36AM  What We May See from Amgens Vectibix in 2017 Market Realist
Aug-14-17 09:36AM  Which Stocks Will Benefit the Most from US-Korea Tensions? Market Realist
09:07AM  Understanding Pfizers Geographical Performance in 2Q17 Market Realist
Aug-07-17 09:08AM  Upadacitinib: Opportunity for AbbVies Long-Term Growth? Market Realist
Aug-02-17 07:37AM  How BMY Is Valued following Its 2Q17 Earnings Market Realist
Aug-01-17 09:06AM  Eli Lillys Elanco in 2Q17 Market Realist
Jul-31-17 06:06PM  Why Pfizer Expects Lower Revenues for 2Q17 Market Realist
03:05PM  Praluent Could Witness Steady Growth in 2017 Market Realist
Jul-28-17 07:40AM  Biogens Spinraza Saw High Growth in 2Q17 Market Realist
Jul-26-17 10:37AM  Understanding Pfizers Sterile Injection Pharmaceuticals Position in 2017 Market Realist
Jul-25-17 09:13AM  Could the S&P 500 Reach a New High This Week? Market Realist
Jul-24-17 10:11AM  Surprise in Store for Healthcare in Q2: Buy Top-Ranked ETFs Zacks
Jul-21-17 10:41AM  A Look at Johnson & Johnsons Segment-Wise Performance Market Realist
09:06AM  Mercks Cardiovascular Drugs Franchise Could Witness a Modest Fall in 2017 Market Realist
Jul-19-17 11:55AM  J&J Brightens Outlook: Healthcare ETFs in Focus Zacks
07:00AM  3 Top Index Funds to Keep You in the Investing Game Motley Fool
Jul-17-17 11:26AM  How Bayer Is Creating Value through Innovation Market Realist
11:26AM  How Bristol-Meyers Squibb Has Benefited from Intangible Assets Market Realist
Jul-14-17 01:05PM  Johnson & Johnsons 2Q17 Estimates: Pharmaceuticals Market Realist
Jul-13-17 09:07AM  TMOs Recent Developments in the Small Molecule Research Field Market Realist
Jul-11-17 08:17AM  The 5 Top Healthcare ETFs Motley Fool
07:36AM  Why Bristol-Myers Squibbs Empliciti Matters in 2017 Market Realist
Jul-10-17 09:08AM  A Look at Merck and Co.s Performance in 2Q17 Market Realist
Jul-06-17 12:31PM  Top Ranked Healthcare ETFs for Long Term Investors Zacks
Jul-03-17 10:39AM  Johnson & Johnsons Valuation on June 30, 2017 Market Realist
09:08AM  Merck & Co.s Segment-Wise Performance in 1Q17 Market Realist
Jun-29-17 09:08AM  Spinraza May Significantly Boost Biogens Revenue Growth Market Realist
Jun-27-17 09:07AM  Pfizers Valuation as of June 22, 2017 Market Realist
Jun-23-17 10:04AM  Top-Ranked Health Care ETFs to Buy Now Zacks
Jun-21-17 09:08AM  Whats in Celgenes Immunology and Inflammation Clinical Pipeline? Market Realist
Jun-20-17 02:06PM  Data from the Checkmate-205 Study Evaluating Opdivo Market Realist
Jun-19-17 10:37AM  FDA Grants Fast-Track Designation to Tanezumab Market Realist
Jun-14-17 04:36PM  How Incytes Revenues Trended in 1Q17 Market Realist
11:31AM  Similar Sector ETFs Not Built The Same ETF.com
10:36AM  A Look at AbbVies Neuroscience Portfolio Market Realist
Jun-12-17 10:37AM  How Ionis Pharmaceuticals Spinraza Performed in 1Q17 Market Realist
Jun-09-17 03:35PM  FDA Approval Boosts Baxters Generic Injectable Business Market Realist
Jun-08-17 11:23AM  3 Top Index Funds in June Motley Fool
Jun-06-17 04:24PM  Beyond tech: How other sectors are driving the stock market MarketWatch
Jun-05-17 09:07AM  Zimmer Biomet Holdings: The Latest Analyst Recommendations Market Realist
09:06AM  Performance of Eli Lillys Neuroscience Products in 1Q17 Market Realist
Jun-02-17 09:06AM  What Does Thermo Fisher Want in the Clinical Mass Spectrometry Business? Market Realist
Jun-01-17 09:08AM  How Long Can Thermo Fisher Scientifics Asia-Pacific Growth Momentum Last? Market Realist
May-31-17 07:39AM  How JNJs Pharmaceuticals Segment Performed in 1Q17 Market Realist
May-26-17 09:07AM  Emerging Markets Drive Abbotts Nutritional Business Growth Market Realist
May-25-17 02:36PM  Is Medical Technology Driving the US Healthcare Industry? Market Realist
12:46PM  Rising Costs Are a Major Issue in the Healthcare Sector Market Realist
May-24-17 07:36AM  1Q17 Performance of Keytruda, Mercks Blockbuster Drug Market Realist
May-22-17 07:36AM  What Orencia Meant to BMY in 1Q17 Market Realist
May-11-17 03:52PM  Biotech ETFs Sink After House Passage of Health-Care Bill The Wall Street Journal
09:08AM  What Happened to Allergans International Segment in 1Q17? Market Realist
May-08-17 11:26AM  Analyzing Allergans 1Q17 Revenue Estimates Market Realist
10:36AM  Pfizers Key Product Developments in 1Q17 Market Realist
09:07AM  What Dragged down BSXs 1Q17 Margins? Market Realist
May-05-17 04:05PM  Pfizers 1Q17 Earnings: A Look at Revenues by Segment Market Realist
May-04-17 02:27PM  Health-care ETFs hold modest gain as House passes Obamacare replacement MarketWatch
The investment seeks to track the performance of a benchmark index. The fund employs an indexing investment approach designed to track the performance of the MSCI US Investable Market Index (IMI)/Health Care 25/50, an index made up of stocks of large, mid-size, and small U.S. companies within the health care sector, as classified under the Global Industry Classification Standard (GICS). The Advisor attempts to replicate the target index by seeking to invest all, or substantially all, of its assets in the stocks that make up the index, in order to hold each stock in approximately the same proportion as its weighting in the index. The fund is non-diversified.